Allogeneic Cell Therapy Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Allogeneic Cell Therapy Market is projected to grow from USD 994.9 million in 2022 to USD 1,570.1 million by 2027 at a CAGR of 9.6% from 2022 to 2027.
Browse 155 Market Data Tables and 133 Figures spread through 156 Pages and in-depth TOC on “Global Allogeneic Cell Therapy Market Forecast to 2027’’ https://www.globalmarketestimates.com/market-report/allogeneic-cell-therapy-market-3894
By Type (T-Cell Therapy, Stem Cell Therapy, Others), By Indication (Cancer, Musculoskeletal Disorders (MSD), Cardiovascular Diseases, Others), By End-User (Hospitals & Clinics, Biotechnology & Pharmaceutical Companies, Research Institutes), By Region (North America, Asia Pacific, Central & South America, Europe, and the Middle East & Africa), End-User Landscape Analysis, Company Market Share Analysis, and Competitor Analysis
Regional Outlook (Revenue, USD Million, 2022-2027) North America
The U.S. Canada Mexico
Europe
Germany UK France Spain Italy Netherlands Rest of Europe
Asia Pacific
China India Japan South Korea Thailand Indonesia Malaysia Singapore Vietnam Rest of APAC
Central & South America
Brazil Argentina Chile Rest of CSA
Middle East & Africa
Saudi Arabia UAE Israel South Africa Rest of MEA
Contact: Yash Jain Email address: yash.jain@globalmarketestimates.com Phone Number: +1 6026667238